Nader joined Frazier Healthcare Partners in 1991 and has served on the firm’s management committee and led its Growth Buyout practice since 1995. Under his leadership, the team has successfully raised over $4 billion of limited partner capital for 11 investment vehicles and has realized over $4 billion in exits.
During his 28-year tenure with the firm, he has been responsible for successful investments in Aspen Education Group (acquired by Bain Capital) where he served as Chairman, CHG Healthcare (acquired by J.W. Childs Associates), Priority Solutions International (acquired by Thermo Fisher NASDAQ: TMO), and Bravo Health (acquired by HealthSpring NYSE: HS). More recently Nader managed the exits of Laboratory Supply Company (acquired by McKesson NYSE: MCK), Solis Mammography (sold to Madison Dearborn), and DSI Renal (merged with U.S. Renal Care and ultimately acquired by Bain Capital). Nader currently serves on the Board of Directors of United Digestive, Northfield Medical, Alteon Health and MedData.
Prior to joining Frazier, he worked at Goldman Sachs & Co. in New York.
New York University Stern School of Business (M.B.A)
University of Pennsylvania (B.A)